Winner Medical Co Ltd (300888) — Capital Reinvestment Ratio
Winner Medical Co Ltd (300888) has a Capital Reinvestment Ratio of 0.58x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥384.40 Million) in capital expenditures (CN¥221.37 Million). See 300888 net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Winner Medical Co Ltd Capital Reinvestment Ratio (2013–2025)
This chart tracks Winner Medical Co Ltd's Capital Reinvestment Ratio across 13 annual periods. Check Winner Medical Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Winner Medical Co Ltd (2013–2025)
Year-by-year Capital Reinvestment Ratio for Winner Medical Co Ltd from 2013 to 2025. For live market cap and broader valuation context, see market cap of Winner Medical Co Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.39x | CN¥1.67 Billion | CN¥647.91 Million | ▼ -45.3% |
| 2024 | 0.71x | CN¥1.27 Billion | CN¥900.89 Million | ▲ +0.5% |
| 2023 | 0.71x | CN¥1.06 Billion | CN¥753.07 Million | ▲ +76.2% |
| 2022 | 0.40x | CN¥2.98 Billion | CN¥1.20 Billion | ▼ -52.9% |
| 2021 | 0.85x | CN¥871.69 Million | CN¥743.27 Million | ▲ +609.1% |
| 2020 | 0.12x | CN¥4.77 Billion | CN¥573.26 Million | ▼ -83.9% |
| 2019 | 0.75x | CN¥599.77 Million | CN¥446.90 Million | ▼ -45.4% |
| 2018 | 1.36x | CN¥467.86 Million | CN¥638.14 Million | ▼ -7.9% |
| 2017 | 1.48x | CN¥357.80 Million | CN¥530.04 Million | ▲ +131.6% |
| 2016 | 0.64x | CN¥450.14 Million | CN¥287.97 Million | ▼ -35.6% |
| 2015 | 0.99x | CN¥269.29 Million | CN¥267.31 Million | ▲ +46.5% |
| 2014 | 0.68x | CN¥203.96 Million | CN¥138.17 Million | ▼ -30.2% |
| 2013 | 0.97x | CN¥124.39 Million | CN¥120.69 Million | — |